TLDR
- Procter & Gamble delivered fiscal Q3 2026 adjusted EPS of $1.59, surpassing the analyst consensus of $1.56
- Quarterly revenue hit $21.24 billion, exceeding Wall Street’s $20.5 billion projection
- Unit volume expanded 2% compared to last year — marking the first positive volume result in 12 months
- The beauty segment outperformed with 5% volume expansion; grooming and health care underperformed
- Management maintained full-year outlook, expecting EPS expansion of 1%–6%
Procter & Gamble delivered an impressive fiscal third quarter performance on Friday, surpassing expectations on both the bottom and top lines. Shares jumped approximately 4% in premarket activity after the announcement.
The Procter & Gamble Company, PG
The consumer products giant recorded adjusted earnings per share of $1.59, beating the Wall Street consensus of $1.56. Total revenue reached $21.24 billion, representing a 7% year-over-year increase and significantly exceeding the $20.5 billion analyst forecast.
Organic sales growth, which excludes the impact of foreign exchange fluctuations, mergers and divestitures, climbed 3%.
Perhaps the most encouraging metric in the quarterly report was unit volume performance. The company achieved 2% volume expansion during the quarter — representing the first company-wide volume increase in twelve months.
For a corporation like P&G, volume growth carries more significance than top-line revenue. It eliminates pricing distortions and provides clearer insight into underlying consumer demand trends.
Chief Financial Officer Andre Schulten characterized the American consumer environment as “stable,” though he acknowledged ongoing bifurcation across demographic segments. This essentially indicates that lower-income households continue facing financial constraints.
The beauty division — featuring brands like Olay, Head & Shoulders and Pantene — emerged as the top performer. This segment recorded 5% volume gains, with strength across personal care, skin care and hair care categories.
Baby, feminine and family care recorded 3% volume growth, powered by increased demand for diaper products and family care brands including Bounty and Charmin.
Fabric and home care, anchored by Tide, registered 2% volume expansion, supported by solid North American consumer demand.
Where It Struggled
Not all divisions delivered positive results. The grooming category — encompassing Gillette and Venus — experienced a 2% volume decline. Health care, which covers Oral-B and Vicks, similarly dropped 2%.
Operating margin registered 21.5%, down from 23.3% during the comparable period last year. Gross margin also fell short of analyst projections, a metric investors should monitor closely.
What’s Ahead
P&G maintained its full-year financial guidance. Management projects sales growth between 1%–5% and net EPS expansion of 1%–6%, with full-year adjusted EPS guidance centered at $6.96.
Chief Executive Shailesh Jejurikar stated the organization is amplifying investments to strengthen consumer engagement despite facing a difficult macroeconomic environment.
One challenge identified for the fourth quarter: an anticipated $150 million expense increase, primarily attributable to elevated transportation costs linked to rising fuel prices.
Free cash flow margin remained stable at 14.3%, essentially matching the prior-year period.
Shares traded up roughly 2.6% to $149.47 immediately following the earnings release, before climbing to approximately 4% higher in premarket trading.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
